Ibuprofen Versus Ketorolac For Postoperative Pain Relief After Cesarean Section
Launched by ALEXANDRIA UNIVERSITY · Jun 14, 2023
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
METHODS
1. Preoperative assessment:
All parturients included in the study will be assessed thoroughly by:
1. Proper history taking
2. Complete clinical examination.
3. All needed laboratory investigations.
2. Patient preparation:
* On arrival to the operative theatre , an 18 G intravenous cannula will be inserted in a peripheral vein
* Steps of general anaesthesia will be explained to the parturients.
Using a multichannel monitor (mindary) iMeC12 SHENZEN MINDRAY BIO-MEDICAL ELECTRONICS CO, LTD, CHINA, the parturients will be continuously monitored for:
1. Non-invasive arterial blood ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Parturients aged 20-30years.
- • 2. ASA physical satatus: II.
- • 3. Anticipated hospital stay for at least 24 hours.
- • 4. Refusal of spinal anaesthesia.
- Exclusion Criteria:
- • 1. Known allergy to the used drugs.
- • 2. Renal and hepatic impairement
- • 3. History of brochial asthma.
- • 4. Low platelets count (\<70000).
- • 5. Bleeding diathesis and with history or risk of intracranial hemorrhage.
- • 6. Obese and morbidly obese parturients.
- • 7. GIT problems as gastritis or GI bleeding.
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Trial Officials
Ahmed S. Shehab, MD
Principal Investigator
Alexandria University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported